Intestinal antibody responses to a live oral poliovirus vaccine challenge among adults previously immunized with inactivated polio vaccine in Sweden
Background Our understanding of the acquisition of intestinal mucosal immunity and the control of poliovirus replication and transmission in later life is still emerging.Methods As part of a 2011 randomised, blinded, placebo-controlled clinical trial of the experimental antiviral agent pocapavir (Eu...
Saved in:
| Main Authors: | Elizabeth B Brickley, Ruth I Connor, Wendy F Wieland-Alter, Marc S Collett, Marianne Hartford, Harrie Van Der Avoort, Austin W Boesch, Joshua A Weiner, Margaret E Ackerman, Mark A McKinlay, Minetaro Arita, Ananda S Bandyopadhyay, John F Modlin, Peter F Wright |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2019-07-01
|
| Series: | BMJ Global Health |
| Online Access: | https://gh.bmj.com/content/4/4/e001613.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Poliovirus shedding after sequential immunization of Sabin-strain inactivated polio vaccines and oral attenuated polio vaccines
by: Yuting Fu, et al.
Published: (2025-04-01) -
Preventing Vaccine-Derived Poliovirus Emergence during the Polio Endgame.
by: Margarita Pons-Salort, et al.
Published: (2016-07-01) -
Monitoring the Risk of Type-2 Circulating Vaccine-Derived Poliovirus Emergence During Roll-Out of Type-2 Novel Oral Polio Vaccine
by: Corey M. Peak, et al.
Published: (2024-11-01) -
Long-Term Persistence of Anti-Poliovirus Antibody Titers After Two-Dose Booster Immunization with Conventional Inactivated Poliovirus Vaccine Among Japanese Adults: 10-Year Observational Study
by: Shinji Fukushima, et al.
Published: (2025-04-01) -
Comparative Randomized Study of Tolerability, Reactogenicity, Immunogenicity and Safety of the Vaccine «BiVac Polio» (Oral Poliovirus Vaccine Type 1,3)
by: Yu. H. Khapchaev, et al.
Published: (2017-06-01)